Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models
Yi, JZ; Lei, XL; Guo, FT; Chen, QB; Chen, XY; Zhao, KT; Zhu, CL; Cheng, XM; Lin, JW; Yin, H; Xia, YC
2023
发表期刊ANTIVIRAL RESEARCH
ISSN0166-3542
卷号215
摘要With 296 million chronically infected individuals worldwide, hepatitis B virus (HBV) causes a major health burden. The major challenge to cure HBV infection lies in the fact that the source of persistence infection, viral episomal covalently closed circular DNA (cccDNA), could not be targeted. In addition, HBV DNA integration, although normally results in replication-incompetent transcripts, considered as oncogenic. Though several studies evaluated the potential of gene-editing approaches to target HBV, previous in vivo studies have been of limited relevance to authentic HBV infection, as the models do not contain HBV cccDNA or feature a complete HBV replication cycle under competent host immune system. In this study, we evaluated the effect of in vivo codelivery of Cas9 mRNA and guide RNAs (gRNAs) by SM-102-based lipid nanoparticles (LNPs) on HBV cccDNA and integrated DNA in mouse and a higher species. CRISPR nanoparticle treatment decreased the levels of HBcAg, HBsAg and cccDNA in AAV-HBV1.04 transduced mouse liver by 53%, 73% and 64% respectively. In HBV infected tree shrews, the treatment achieved 70% reduction of viral RNA and 35% reduction of cccDNA. In HBV transgenic mouse, 90% inhibition of HBV RNA and 95% inhibition of DNA were observed. CRISPR nanoparticle treatment was well tolerated in both mouse and tree shrew, as no elevation of liver enzymes and minimal off -target was observed. Our study demonstrated that SM-102-based CRISPR is safe and effective in targeting HBV episomal and integration DNA in vivo. The system delivered by SM-102-based LNPs may be used as a po-tential therapeutic strategy against HBV infection.
收录类别SCI
语种英语
文献类型期刊论文
条目标识符http://ir.kiz.ac.cn/handle/152453/14366
专题科研部门_灵长类动物生殖与干细胞(林江维)
推荐引用方式
GB/T 7714
Yi, JZ,Lei, XL,Guo, FT,et al. Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models[J]. ANTIVIRAL RESEARCH,2023,215.
APA Yi, JZ.,Lei, XL.,Guo, FT.,Chen, QB.,Chen, XY.,...&Xia, YC.(2023).Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models.ANTIVIRAL RESEARCH,215.
MLA Yi, JZ,et al."Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models".ANTIVIRAL RESEARCH 215(2023).
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
2024053122.pdf(12158KB)期刊论文出版稿开放获取CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yi, JZ]的文章
[Lei, XL]的文章
[Guo, FT]的文章
百度学术
百度学术中相似的文章
[Yi, JZ]的文章
[Lei, XL]的文章
[Guo, FT]的文章
必应学术
必应学术中相似的文章
[Yi, JZ]的文章
[Lei, XL]的文章
[Guo, FT]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。